Clinical Observation of Fuyankang Combined with Azithromycin in the Treatment of Pelvic Inflammatory Disease
10.6039/j.issn.1001-0408.2016.29.21
- VernacularTitle:妇炎康联合阿奇霉素治疗盆腔炎性疾病的临床观察
- Author:
Xiuru REN
;
Huifang ZHU
;
Hongjie SHEN
;
Jin WANG
- Publication Type:Journal Article
- Keywords:
Fuyankang;
Azithromycin;
Integrated traditional and western medicine;
Pelvic inflammatory disease;
CRP;
IL-2
- From:
China Pharmacy
2016;27(29):4099-4100,4101
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To observe the clinical efficacy and safety of Fuyankang combined with azithromycin in the treat-ment of pelvic inflammatory disease. METHODS:90 patients with pelvic inflammatory disease were selected and randomly divided into observation group and control group,with 45 cases in each group. Control group was given Lactose acid azithromycin for injec-tion 500 mg,ivgtt,qd,and then Azithromycin capsule 250 mg,po,qd;observation group was additionally given Fuyankang Tab-let 1.56 g,tid,on the basis of control group. A treatment course of 2 groups lasted for 7 d,and both received 3 courses of treat-ment. Clinical efficacies of 2 groups were observed as well as the level of CRP,IL-2 and life quality score before and after treat-ment,and the occurrence of ADR was compared between 2 groups. RESULTS:Total effective rate of observation group was 97.78%,which was significantly higher than that of control group (86.67%),with statistical significance (P<0.05). The level of CRP,IL-2 and life quality score of 2 groups were improved significantly after treatment,and the observation group was more better than the control group,with statistical significance (P<0.05). No obvious ADR was found in 2 groups during treatment. CONCLUSIONS:Fuyankang combined with Azithromycin is effective for pelvic inflammatory disease,and can improve the quali-ty of life,reduce inflammation cytokines infiltration and the generation of inflammatory medium with good safety.
